Catatan efek · kuartal yang diarsipkan
BMY
Bristol-Myers Squibb Company · Healthcare · Drug Manufacturers - General
19Pemegang yang dilacak
—Δ pemegang
159.17MSaham yang dipegang
$6.60BNilai yang dilaporkan
+0Posisi baru
−0Keluar
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 174 | +1 | 1.33B | $76.47B | +6 | −4 |
| Q1 2026 | 175 | +1 | 1.27B | $76.90B | +4 | −4 |
| Q4 2025 | 173 | +1 | 1.36B | $73.29B | +2 | — |
| Q3 2025 | 26 | 0 | 840.35M | $37.89B | — | −1 |
| Q2 2025 | 24 | +1 | 649.62M | $30.06B | +2 | −1 |
| Q1 2025 | 20 | 0 | 256.22M | $15.62B | +1 | −1 |
| Q4 2024 | 20 | -1 | 253.42M | $14.33B | — | −1 |
| Q3 2024 | 20 | +1 | 169.93M | $8.78B | +1 | — |
| Q2 2024 | 19 | — | 159.17M | $6.60B | — | — |
Siapa yang memegangnya · Q2 2024
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasif) | 42.17M | — | $1.75B | 0.2% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasif) | 42.17M | — | $1.75B | 0.2% | n/c | 1 | SEC ↗ |
| 3 | Norges Bank ✦ (pasif) | 32.59M | — | $1.35B | 0.2% | n/c | 1 | SEC ↗ |
| 4 | PRIMECAP Management ✦ | 23.50M | — | $975.90M | 0.7% | n/c | 1 | SEC ↗ |
| 5 | Dodge & Cox ✦ | 15.77M | — | $654.80M | 0.4% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 15.30M | — | $635.43M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 15.30M | — | $635.43M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 11.01M | — | $455.66M | 0.5% | n/c | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 11.01M | — | $455.66M | 0.5% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 11.01M | — | $455.66M | 0.5% | n/c | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 6.17M | — | $256.44M | 0.6% | n/c | 1 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 2.92M | — | $121.25M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 2.68M | — | $111.15M | 0.2% | n/c | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 2.68M | — | $111.15M | 0.2% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 2.68M | — | $111.15M | 0.2% | n/c | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 2.68M | — | $111.15M | 0.2% | n/c | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 2.68M | — | $111.15M | 0.2% | n/c | 1 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 2.45M | — | $101.92M | 0.2% | n/c | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 2.45M | — | $101.92M | 0.2% | n/c | 1 | SEC ↗ |
| 20 | Millennium Management ✦ | 1.49M | — | $61.91M | 0.1% | n/c | 1 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 871.63K | — | $36.20M | 0.1% | n/c | 1 | SEC ↗ |
| 22 | Point72 Asset Management ✦ | 637.99K | — | $26.50M | 0.1% | n/c | 1 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 554.99K | — | $23.05M | 0.1% | n/c | 1 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 286.84K | — | $11.91M | 0.2% | n/c | 1 | SEC ↗ |
| 25 | Marshall Wace ✦ | 255.73K | — | $10.62M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Marshall Wace ✦ | 255.73K | — | $10.62M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Fisher Asset Management ✦ | 228.00K | — | $9.47M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Wellington Management ✦ | 166.71K | — | $6.92M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Wellington Management ✦ | 166.71K | — | $6.92M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Wellington Management ✦ | 166.71K | — | $6.92M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Wellington Management ✦ | 166.71K | — | $6.92M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | GAMCO Investors ✦ | 111.44K | — | $4.63M | 0.1% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 6.60K saham, $400 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q2 2024 ·
Metodologi ·
Dapatkan ini melalui API